P19L (p.Pro19Leu) variant of ADD1 (Alpha-adducin)

P19L (p.Pro19Leu) in ADD1 (Alpha-adducin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.54 / 1. The record also includes population frequency data and structural context.

P19L (p.Pro19Leu) variant details